Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 3
2009 1
2010 1
2011 1
2012 3
2013 2
2014 5
2015 3
2016 10
2017 9
2018 2
2020 4
2021 6
2022 3
2023 3
2024 4
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

55 results

Results by year

Filters applied: . Clear all
Page 1
Breast cancer in young women.
Radecka B, Litwiniuk M. Radecka B, et al. Among authors: litwiniuk m. Ginekol Pol. 2016;87(9):659-663. doi: 10.5603/GP.2016.0062. Ginekol Pol. 2016. PMID: 27723074 Free article. Review.
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.
Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, Abraham M, Medeiros Alencar VH, Badran A, Bonfill X, Bradbury J, Clarke M, Collins R, Davis SR, Delmestri A, Forbes JF, Haddad P, Hou MF, Inbar M, Khaled H, Kielanowska J, Kwan WH, Mathew BS, Mittra I, Müller B, Nicolucci A, Peralta O, Pernas F, Petruzelka L, Pienkowski T, Radhika R, Rajan B, Rubach MT, Tort S, Urrútia G, Valentini M, Wang Y, Peto R; Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group. Davies C, et al. Lancet. 2013 Mar 9;381(9869):805-16. doi: 10.1016/S0140-6736(12)61963-1. Lancet. 2013. PMID: 23219286 Free PMC article. Clinical Trial.
Follow-up after breast cancer treatment.
Załuska-Kusz J, Litwiniuk M. Załuska-Kusz J, et al. Among authors: litwiniuk m. Rep Pract Oncol Radiother. 2022 Oct 31;27(5):875-880. doi: 10.5603/RPOR.a2022.0104. eCollection 2022. Rep Pract Oncol Radiother. 2022. PMID: 36523801 Free PMC article.
The utility of the 21-gene Oncotype DX Breast Recurrence Score® assay in node-negative breast cancer patients - the final analysis of the Polish real-life survey PONDx.
Jarząb M, Litwiniuk M, Innis P, Łacko A, Enderle G, Czartoryska-Arłukowicz B, Talerczyk M, Streb J, Wysocki P, Suchodolska G, Szymanowski B, Duchnowska R. Jarząb M, et al. Among authors: litwiniuk m. Contemp Oncol (Pozn). 2024;28(3):245-252. doi: 10.5114/wo.2024.144222. Epub 2024 Oct 15. Contemp Oncol (Pozn). 2024. PMID: 39512534 Free PMC article.
Coping with cancer and a history of health-related events.
Homa M, Ziarko M, Litwiniuk M. Homa M, et al. Among authors: litwiniuk m. Rep Pract Oncol Radiother. 2023 Apr 6;28(1):66-73. doi: 10.5603/RPOR.a2023.0012. eCollection 2023. Rep Pract Oncol Radiother. 2023. PMID: 37122910 Free PMC article.
Systematic review of the needs and health-related quality of life domains relevant to people surviving cancer in Europe.
Amat-Fernandez C, Garin O, Luer-Aguila R, Pardo Y, Briseño R, Lizano-Barrantes C, Rojas-Concha L, S Y Thong M, Apolone G, Brunelli C, Caraceni A, Couespel N, Bos N, Groenvold M, Kaasa S, Ciliberto G, Lombardo C, Pietrobon R, Pravettoni G, Sirven A, Vachon H, Gilbert A, Velikova G, Ferrer M; EUonQoL Working Group. Amat-Fernandez C, et al. Qual Life Res. 2025 Apr;34(4):913-936. doi: 10.1007/s11136-024-03884-w. Epub 2025 Jan 23. Qual Life Res. 2025. PMID: 39847267 Free PMC article.
55 results